Centessa Pharmaceuticals PLC ADR
Price & Volume
Stats
See more52W Range | $7.75-$19.09 |
Market Cap | $1.8B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $6.8M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $6.8M |
Diluted EPS | -$2.06 |
News
See moreYahoo Finance • last month
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024
Yahoo Finance • 2 months ago
Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting
Yahoo Finance • last year
Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa Pharmaceuticals
Yahoo Finance • last year
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023
About
CEO | Dr. Saurabh Saha M.D., Ph.D. |
CFO | Mr. John J. Crowley CPA |
Address | 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 77 |
